Eton Pharmaceuticals Announces $10 Million Debt Facility with SWK Holdings
November 13, 2019 16:55 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019
November 06, 2019 16:05 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection
October 22, 2019 07:00 ET
|
Eton Pharmaceuticals
~ Biorphen is the First and Only Ready-to-Use FDA-Approved Injectable Formulation of Phenylephrine ~ ~ Biorphen Eliminates Need for Compounding, Reducing Risks for Unsafe Injection Practices,...
Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth Conference
September 03, 2019 16:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Announces Second Quarter Financial Results and Highlights Business Progress
August 06, 2019 16:01 ET
|
Eton Pharmaceuticals
ET-203 NDA submitted, Three Additional Product Submissions Expected in 2019 ET-105 Acquisition Closed & Application Assigned PDUFA Date of March 17, 2020Company to Host Conference Call and Webcast...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
August 01, 2019 08:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019
July 30, 2019 08:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., July 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Provides Update on EM-100 Program
July 12, 2019 16:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., July 12, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
June 13, 2019 16:01 ET
|
Eton Pharmaceuticals
Unique patent-pending formulation of lamotrigine addresses significant unmet need in pediatric epilepsy patientsNDA was submitted in May 2019; product launch anticipated in 1H 2020Lamotrigine market...
Eton Pharmaceuticals to Present at 20th Annual B. Riley FBR Investor Conference
May 15, 2019 16:01 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 15, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...